SUPPLEMENTARY INFORMATION:

Members of the public may listen to the ( printed page 50801) discussion by dialing the following Conference Call Toll-Free Number: 1-800-367-2403; conference ID: 9800799. Please be advised that before being placed into the conference call, the operator will ask callers to provide their names, their organizational affiliations (if any), and an email address (if available) prior to placing callers into the conference room. Callers can expect to incur charges for calls they initiate over wireless lines, and the Commission will not refund any incurred charges. Callers will incur no charge for calls they initiate over land-line connections to the toll-free phone number.

Persons with hearing impairments may also follow the discussion by first calling the Federal Relay Service (FRS) at 1-800-877-8339 and provide the FRS operator with Conference Call Toll-Free Number: 1-800-367-2403; conference ID: 9800799. Members of the public are invited to submit written comments; the comments must be received within 30 days of the meeting date. Written comments may be emailed to Mallory Trachtenberg at mtrachtenberg@usccr.gov. Persons who desire additional information may contact the Regional Programs Unit at (202) 809-9618.

Records and documents discussed during the meeting will be available for public viewing as they become available at the FACA Link and clicking on the “Meeting Details” and “Documents” links. Records generated from this meeting may also be inspected and reproduced at the Midwestern Regional Office, as they become available, both before and after the meeting. Persons interested in the work of this advisory committee are advised to go to the Commission's website, www.usccr.gov, or to contact the Midwestern Regional Office at the above phone number, email address.

Agenda: Wednesday, August 19, 2020 at 3:00 p.m. (CDT)

I. Welcome and Roll Call

II. Announcements and Updates

III. Approval of Minutes from the Last Meeting

IV. Discussion: Maternal Health Disparities of Native American Women

V. Next Steps

VI. Public Comment

VII. Adjournment

85 FR 50800